Zoran Rakusic

Dr. Zoran Rakusic

University Hospital Center Zagreb
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Tumori Journal
Verified
Journal Article
Closed access
PDF file
VBVanja Vucicevic Boras
Vanja Vucicevic Boras
Aleksandra FucicAleksandra Fucic
Aleksandra Fucic
MVMihajlo Virag
Mihajlo Virag
DGDragana Gabric
Dragana Gabric
IBIgor Blivajs
Igor Blivajs
DVDanko Velimir Vrdoljak
Danko Velimir Vrdoljak
The worldwide annual incidence of oral squamous cell carcinoma (OSCC) is over 300,000 cases with a mortality rate of 48%. This cancer type accounts for 90% of all oral cancers, with the highest incidence in men over 50 years of age. A significantly increased risk of developing OSCC exists among smokers and people who consume alcohol daily. OSCC is an aggressive cancer that metastasizes rapidly. Despite the development of new therapies in the treatment of OSCC, no significant increase in 5-year survival has been recorded in the past decades. The latest research suggests focus should be put on examining tumor stroma activation within OSCC, as the stroma may contain cells that can produce signal molecules and a microenvironment crucial for the development of metastases. The aim of this review is to provide an insight into the factors that activate OSCC stroma and hence faciliate neoplastic progression. It is based on the currently available data on the role and interaction between metalloproteinases, cytokines, growth factors, hypoxia factor and extracellular adhesion proteins in the stroma of OSCC and neoplastic cells. Their interplay is additionally presented using the Systems Biology Graphical Notation in order to sublimate the collected knowledge and enable the more efficient recognition of possible new biomarkers in the diagnostics and follow-up of OSCC or in finding new therapeutic targets.

26 June 2019 in Central European Journal of Public Health
Verified
Journal Article
Closed access
VBVanja Vučičević Boras
Vanja Vučičević Boras
AFAleksandra Fučić
Aleksandra Fučić
SBSandra Baranović
Sandra Baranović
IBIgor Blivajs
Igor Blivajs
MMMaja Milenović
Maja Milenović
MBMarco Bruzzone
Marco Bruzzone
Objectives: The high incidence of head and neck cancer (HNC), significantly associated with living environment and behaviour, can be prevented more efficiently. The aim of this study was to evaluate the environmental and behavioural risk facto...

1 January 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
NPNatalija Dedić Plavetić
Natalija Dedić Plavetić
ZRZoran Rakusic
Zoran Rakusic
DODavid Ozretić
David Ozretić
LSLuka Simetić
Luka Simetić
AKAna Mišir Krpan
Ana Mišir Krpan
VBVesna Bišof
Vesna Bišof
Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, and visual disturbances. It can occur in many different clinical entities such as severe hypertension and pre-eclampsia, or due to cytotoxic or immunosuppressive therapies. The pathogenesis of PRES is unclear, with dysregulated cerebral auto-regulation and endothelial dysfunction as important mechanisms proposed. Endothelial dysfunction is important especially in cases associated with cytotoxic therapies. Herein, we describe a patient with PRES with fatal outcome, who presented 5 days after the infusion of cycle 1 of irinotecan hydrochloride, leucovorin calcium, and fluorouracil (FOLFIRI) regimen chemotherapy, without prior hypertension and other comorbidity, suggesting a link between PRES and FOLFIRI regimen. To our knowledge, this case report is the first describing PRES after FOLFIRI regimen, although others have described PRES after FOLFIRI with bevacizumab in colonic cancer patients.

16 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
AJAntonia Jakovčević
Antonia Jakovčević
KZKamelija Zarkovic
Kamelija Zarkovic
DJDanica Jakovčević
Danica Jakovčević
ZRZoran Rakusic
Zoran Rakusic
DPDrago Prgomet
Drago Prgomet
Neven ZarkovicNeven Zarkovic
Neven Zarkovic
Tumor growth is associated with oxidative stress, which causes lipid peroxidation. The most intensively studied product of lipid peroxidation is 4-hydroxy-2-nonenal (HNE), which is considered as a “second messenger of free radicals” that binds to proteins and acts as a growth-regulating signaling factor. The incidence of squamous cell carcinoma of the oropharynx is associated with smoking, alcohol and infection of human papilloma virus (HPV), with increasing incidence world-wide. The aim of this retrospective study involving 102 patients was to determine the immunohistochemical appearance of HNE-protein adducts as a potential biomarker of lipid peroxidation in squamous cell carcinoma of the oropharynx. The HNE-protein adducts were detected in almost all tumor samples and in the surrounding non-tumorous tissue, while we found that HNE is differentially distributed in squamous cell carcinomas in dependence of clinical stage and histological grading of these tumors. Namely, the level of HNE-immunopositivity was increased in comparison to the normal oropharyngeal epithelium in well- and in moderately-differentiated squamous cell carcinoma, while it was decreasing in poorly differentiated carcinomas and in advanced stages of cancer. However, more malignant and advanced cancer was associated with the increase of HNE in surrounding, normal tissue. This study confirmed the onset of lipid peroxidation, generating HNE-protein adducts that can be used as a valuable bioactive marker of carcinogenesis in squamous cell carcinoma of the oropharynx, as well as indicating involvement of HNE in pathophysiological changes of the non-malignant tissue in the vicinity of cancer.

1 February 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Ksenija BožinovićKsenija Božinović
Ksenija Božinović
Ivan SabolIvan Sabol
Ivan Sabol
ZRZoran Rakusic
Zoran Rakusic
AJAntonia Jakovčević
Antonia Jakovčević
MŠMario Šekerija
Mario Šekerija
MGMagdalena Grce
Magdalena Grce
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide. Main HNSCC risk factors are tobacco, alcohol, and high-risk human papillomavirus (HPV). HPV+ oropharyngeal squamous cell cancer (OPSCC) usually have different etiology, increasing incidence and often show an improved survival when compared to HPV-negative cases. The objective of the current study was to retrospectively examine the influence of HPV on the survival of OPSCC patients in a non-Western population setting. We determined the presence of HPV DNA and/or RNA in 99 formalin-fixed paraffin embedded (FFPE) tissue samples of OPSCC patients treated between 2002 and 2015. Patients were compared based on laboratory, demographic, clinical, life style characteristics and survival. HPV RNA was found in 29.3% cases. However, groups based on HPV data (either RNA, DNA or retrospectively collected p16 staining) did not show significant differences. Overall, 5-year survival was 30% with minimal influence of the HPV positivity. The HPV influence on survival of OPSCC patients is not identical between populations probably due to other factors overshadowing the HPV effect. This should be taken into account when treatment or policy decisions are made in each particular setting.

3 June 2014 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
VBVesna Bisof
Vesna Bisof
ZRZoran Rakusic
Zoran Rakusic
MDMarija Despot
Marija Despot